Cargando…
CA125 as a predictor of endometrial cancer lymphovascular space invasion and lymph node metastasis for risk stratification in the preoperative setting
Endometrial cancer (EC) is the most common malignancy of the female reproductive system. Cancer antigen 125 (CA125) is a serum tumor marker widely reported in EC patients, particularly those with poor prognostic factors such as grade 3 tumors, deep myometrial invasion, lymph node metastasis (LNM), a...
Autores principales: | Shawn LyBarger, K., Miller, Hunter A., Frieboes, Hermann B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9671890/ https://www.ncbi.nlm.nih.gov/pubmed/36396713 http://dx.doi.org/10.1038/s41598-022-22026-1 |
Ejemplares similares
-
Preoperative CA125 and fibrinogen in patients with endometrial cancer: a risk model for predicting lymphovascular space invasion
por: Zhou, Xingchen, et al.
Publicado: (2017) -
Preoperative CA-125 in low-grade endometrial cancer: risk stratification and implications for treatment
por: Kwon, Janice S.
Publicado: (2019) -
Preoperative CA125 Significantly Improves Risk Stratification in High-Grade Endometrial Cancer
por: Lombaers, Marike S., et al.
Publicado: (2023) -
Lymph node metastasis and pattern of recurrence in clinically early stage endometrial cancer with positive lymphovascular space invasion
por: Mahdi, Haider, et al.
Publicado: (2015) -
What is the prognostic importance of lymphovascular space invasion in the absence of lymph node metastasis for early-stage endometrial cancer?
por: Aslan, Koray, et al.
Publicado: (2021)